MedPath

Leritrelvir

Generic Name
Leritrelvir

Overview

No overview information available.

Background

No background information available.

Indication

用于治疗轻中度新型冠状病毒感染(COVID-19)的成年患者。

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1
Completed
Posted: 2023/12/13
Sponsor:
Guangdong Raynovent ...
Phase 1
Completed
Posted: 2023/12/07
Sponsor:
Guangdong Raynovent ...
Phase 3
Completed
Posted: 2022/11/17
Sponsor:
Guangdong Raynovent ...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath